Midwest Regional Dance Crew Competition benefits Cancer Research

Midwest Regional Dance Crew Competition presents Midwest Regional Dance Crew Competition -- Saturday, May 08, 2010 -- Wichita, KS This event is a fundraiser supporting the Voices of Survivors Foundation and Livestrong---cancer organizations focused on cancer advocacy, awareness and cancer survivors. You may learn more about these organizations at www.voicesofsurvivors.org and livestrong.org
11:00 AM – Individual/Dance Crew Sign-in
1:00 PM – First Round Starts
3:00 PM – Finalists Announced
5:00 PM – Finalist Competition Starts

Individual/Crew Performance: Time limit 2 min. 30 sec.
Experienced judging panel – Concessions available•

Registration: $20 per person or $100 per crew
Early Bird Registration and Payment due May 1, 2010
After May 1, Registration Fee is $25 per person or $125 per crew.
Make checks payable to: Midwest Dance Crew
Mail registration fee to:
Carrie Courtney
13825 Pinnacle Drive
Wichita, KS 67230

General Admission Tickets to watch the show: $10.00
Advance General Admission Tickets may be purchased via Eventbrite or at the door.
Limited Tickets available.

QUESTIONS: please email Carrie Courtney at ksdancecrews@gmail.com or
Call 316-200-5725
www.ksdancecrews.eventbrite.com

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap